Inflammageing and metaflammation: The yin and yang of type 2 diabetes

[1]  Jared M. Campbell,et al.  Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis , 2017, Ageing Research Reviews.

[2]  M. Mattson,et al.  Impact of intermittent fasting on health and disease processes , 2017, Ageing Research Reviews.

[3]  S. Simpson,et al.  Dietary protein, aging and nutritional geometry , 2017, Ageing Research Reviews.

[4]  S. Griffey,et al.  A Ketogenic Diet Extends Longevity and Healthspan in Adult Mice. , 2017, Cell metabolism.

[5]  E. Mannucci,et al.  Perspectives on cardiovascular effects of incretin-based drugs: From bedside to bench, return trip. , 2017, International journal of cardiology.

[6]  Y. Suh,et al.  Circulating miRNAs and miRNA shuttles as biomarkers: Perspective trajectories of healthy and unhealthy aging , 2017, Mechanisms of Ageing and Development.

[7]  A. Kalsbeek,et al.  Dietary sugars, not lipids, drive hypothalamic inflammation , 2017, Molecular metabolism.

[8]  T. Lüscher,et al.  Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels , 2017, Diabetes.

[9]  P. Sivaramakrishnan,et al.  Microbial Genetic Composition Tunes Host Longevity , 2017, Cell.

[10]  W. Wagner.  Epigenetic aging clocks in mice and men , 2017, Genome Biology.

[11]  Caroline L. Wilson,et al.  Cellular senescence drives age-dependent hepatic steatosis , 2017, Nature Communications.

[12]  G. Sesti,et al.  Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-&kgr;B Signaling Pathway in HepG2 Cells , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[13]  C. Franceschi,et al.  Mediterranean diet and inflammaging within the hormesis paradigm , 2017, Nutrition reviews.

[14]  R. Burcelin,et al.  A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism. , 2017, Cell metabolism.

[15]  C. Drevon,et al.  Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation , 2017, Nutrition reviews.

[16]  L. Rydén,et al.  Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes. , 2017, The lancet. Diabetes & endocrinology.

[17]  F. Marotta,et al.  Gut microbiota: A player in aging and a target for anti-aging intervention , 2017, Ageing Research Reviews.

[18]  M. Mattson,et al.  Toll-like Receptor 4 Mediates Fat, Sugar and Umami Taste Preference, and Food Intake and Body Weight Regulation , 2017, Obesity.

[19]  J. Kirkland,et al.  Cellular Senescence: A Translational Perspective , 2017, EBioMedicine.

[20]  Björn Eliasson,et al.  Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes , 2017, The New England journal of medicine.

[21]  M. Surette,et al.  Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction , 2017, Cell host & microbe.

[22]  S. Bonner-Weir,et al.  β Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance. , 2017, Cell metabolism.

[23]  Xinghui Sun,et al.  Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy , 2017, Endocrine reviews.

[24]  C. Franceschi,et al.  Inflammaging and ‘Garb-aging’ , 2017, Trends in Endocrinology & Metabolism.

[25]  Lifang Yang,et al.  Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes , 2017, Oxidative medicine and cellular longevity.

[26]  G. Hotamışlıgil.  Inflammation, metaflammation and immunometabolic disorders , 2017, Nature.

[27]  M. Levine,et al.  Epigenetic clock analysis of diet, exercise, education, and lifestyle factors , 2017, Aging.

[28]  Julie B. Sneddon,et al.  Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes , 2017, Cell.

[29]  K. Maiese.  Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease. , 2017, Current neurovascular research.

[30]  F. Pattou,et al.  Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation , 2017, Nature Immunology.

[31]  M. Kyba,et al.  Cellular Aging Contributes to Failure of Cold-Induced Beige Adipocyte Formation in Old Mice and Humans. , 2017, Cell metabolism.

[32]  C. Franceschi.  Healthy ageing in 2016: Obesity in geroscience — is cellular senescence the culprit? , 2017, Nature Reviews Endocrinology.

[33]  M. Mazidi,et al.  Impact of Probiotic Administration on Serum C-Reactive Protein Concentrations: Systematic Review and Meta-Analysis of Randomized Control Trials , 2017, Nutrients.

[34]  Christopher E. Carr,et al.  An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer , 2016, Cell.

[35]  B. Friguet,et al.  Impaired energy metabolism of senescent muscle satellite cells is associated with oxidative modifications of glycolytic enzymes , 2016, Aging.

[36]  T. Baum,et al.  Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue–Derived Mesenchymal Stem Cells In Vitro , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  J. Lykkesfeldt,et al.  Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies , 2016, Current diabetes reviews.

[38]  W. D. de Vos,et al.  A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice , 2016, Nature Medicine.

[39]  X. Terra,et al.  Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity , 2016, Nutrition Research Reviews.

[40]  M. Karin,et al.  Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction , 2016, Cell.

[41]  C. Conover,et al.  Senescent intimal foam cells are deleterious at all stages of atherosclerosis , 2016, Science.

[42]  Haichao Wang,et al.  PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation , 2016, Nature Communications.

[43]  D. Drucker,et al.  Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance. , 2016, Endocrine reviews.

[44]  A. Nishiyama,et al.  Increase in tumor suppressor Arf compensates gene dysregulation in in vitro aged adipocytes , 2016, Biogerontology.

[45]  B. Isermann,et al.  Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy , 2016, Scientific Reports.

[46]  P. Schrauwen,et al.  Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial , 2016, Diabetes Care.

[47]  A. Novials,et al.  Circulating microRNAs as biomarkers for metabolic disease. , 2016, Best practice & research. Clinical endocrinology & metabolism.

[48]  S. Sahoo,et al.  Exosomes in Diabetic Cardiomyopathy: The Next-Generation Therapeutic Targets? , 2016, Diabetes.

[49]  K. Irani,et al.  Vascular microRNA-204 is remotely governed by the microbiome and impairs endothelium-dependent vasorelaxation by downregulating Sirtuin1 , 2016, Nature Communications.

[50]  Amy R. Cameron,et al.  Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status , 2016, Circulation research.

[51]  R. Testa,et al.  The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory , 2016, Endocrine.

[52]  Carlos López-Otín,et al.  Metabolic Control of Longevity , 2016, Cell.

[53]  D. Leroith,et al.  Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications , 2016, Diabetes Care.

[54]  R. Testa,et al.  Leukocyte telomere length and mortality risk in patients with type 2 diabetes , 2016, Oncotarget.

[55]  D. Drucker.  The Cardiovascular Biology of Glucagon-like Peptide-1. , 2016, Cell metabolism.

[56]  J. Rathmell,et al.  A guide to immunometabolism for immunologists , 2016, Nature Reviews Immunology.

[57]  A. Gudkov,et al.  Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells , 2016, Aging.

[58]  R. Testa,et al.  Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity? , 2016, Diabetes, obesity & metabolism.

[59]  J. Campisi,et al.  From Ancient Pathways to Aging Cells-Connecting Metabolism and Cellular Senescence. , 2016, Cell metabolism.

[60]  S. Kritchevsky,et al.  Metformin as a Tool to Target Aging. , 2016, Cell metabolism.

[61]  T. Morgan,et al.  A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. , 2016, Cell reports.

[62]  S. Rampelli,et al.  Gut Microbiota and Extreme Longevity , 2016, Current Biology.

[63]  T. Misteli,et al.  Repression of the Antioxidant NRF2 Pathway in Premature Aging , 2016, Cell.

[64]  Fabiola Olivieri,et al.  “Inflammaging” as a Druggable Target: A Senescence-Associated Secretory Phenotype—Centered View of Type 2 Diabetes , 2016, Oxidative medicine and cellular longevity.

[65]  Dudley Lamming,et al.  Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer , 2016, Aging cell.

[66]  K. Nakayama,et al.  Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription , 2016, Nature Communications.

[67]  J. Geleijnse,et al.  Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies. , 2016, The American journal of clinical nutrition.

[68]  A. Shimatsu,et al.  Hyperglycemia and Inflammatory Property of Circulating Monocytes are Associated with Inflammatory Property of Carotid Plaques in Patients Undergoing Carotid Endarterectomy , 2016, Journal of atherosclerosis and thrombosis.

[69]  Cory B. Giles,et al.  Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors , 2016, Aging cell.

[70]  R. de Cabo,et al.  Metformin‐mediated increase in DICER1 regulates microRNA expression and cellular senescence , 2016, Aging cell.

[71]  A. Klochendler,et al.  p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion , 2016, Nature Medicine.

[72]  M. Jensen,et al.  Exercise Prevents Diet-Induced Cellular Senescence in Adipose Tissue , 2016, Diabetes.

[73]  Luca Tiano,et al.  Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells , 2016, Oncotarget.

[74]  B. Okopień,et al.  Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner , 2016, Pharmacological reports : PR.

[75]  P. Valensi,et al.  Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group , 2016, Cardiovascular Diabetology.

[76]  A. Pezeshki,et al.  Naturally occurring p16Ink4a-positive cells shorten healthy lifespan , 2016, Nature.

[77]  Dong-Hyun Kim,et al.  Gut microbiota lipopolysaccharide accelerates inflamm-aging in mice , 2016, BMC Microbiology.

[78]  Ruisheng Song.  Mechanism of Metformin: A Tale of Two Sites , 2016, Diabetes Care.

[79]  D. Giugliano,et al.  Anti-inflammatory Effect of Mediterranean Diet in Type 2 Diabetes Is Durable: 8-Year Follow-up of a Controlled Trial , 2016, Diabetes Care.

[80]  P. Clifton,et al.  Polyphenols and Glycemic Control , 2016, Nutrients.

[81]  I. Sandovici,et al.  Ageing is associated with molecular signatures of inflammation and type 2 diabetes in rat pancreatic islets , 2015, Diabetologia.

[82]  M. Jensen,et al.  Targeting senescent cells enhances adipogenesis and metabolic function in old age , 2015, eLife.

[83]  Jun Wang,et al.  Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota , 2015, Nature.

[84]  D. Baker,et al.  Cellular senescence in aging and age-related disease: from mechanisms to therapy , 2015, Nature Medicine.

[85]  A. Walker,et al.  Human fibrocyte-derived exosomes accelerate wound healing in genetically diabetic mice. , 2015, Biochemical and biophysical research communications.

[86]  Yang Zheng,et al.  Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation , 2015, Oxidative medicine and cellular longevity.

[87]  T. Weichhart,et al.  Regulation of innate immune cell function by mTOR , 2015, Nature Reviews Immunology.

[88]  R. Kitsis,et al.  MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype. , 2015, Molecular cell.

[89]  M. Bennett,et al.  Senescent Vascular Smooth Muscle Cells Drive Inflammation Through an Interleukin-1α–Dependent Senescence-Associated Secretory Phenotype , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[90]  Yan Wang,et al.  Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway , 2015, Scientific Reports.

[91]  S. Ryter,et al.  mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation. , 2015, Cell reports.

[92]  P. Nelson,et al.  MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation , 2015, Nature Cell Biology.

[93]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[94]  N. LeBrasseur,et al.  Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity , 2015, Diabetes.

[95]  C. Ling,et al.  DNA methylation as a diagnostic and therapeutic target in the battle against Type 2 diabetes. , 2015, Epigenomics.

[96]  T. Szkudelski,et al.  Resveratrol and diabetes: from animal to human studies. , 2015, Biochimica et biophysica acta.

[97]  R. Testa,et al.  Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes , 2015, Clinical Epigenetics.

[98]  K. Maiese.  New Insights for Oxidative Stress and Diabetes Mellitus , 2015, Oxidative medicine and cellular longevity.

[99]  L. Rodella,et al.  Metabolic syndrome, aging and involvement of oxidative stress. , 2015, Aging and disease.

[100]  M. Vidaković,et al.  From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition? , 2015, Clinical Epigenetics.

[101]  Longlong Yang,et al.  SIRT1 Is a Regulator in High Glucose-Induced Inflammatory Response in RAW264.7 Cells , 2015, PloS one.

[102]  Tian-Yu Zhao,et al.  Application of Berberine on Treating Type 2 Diabetes Mellitus , 2015, International journal of endocrinology.

[103]  R. Natarajan,et al.  Epigenetic mechanisms in diabetic complications and metabolic memory , 2015, Diabetologia.

[104]  A. El-Sohemy,et al.  Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults , 2015, PloS one.

[105]  Rui Cheng,et al.  Angiogenesis in diabetes and obesity , 2015, Reviews in Endocrine and Metabolic Disorders.

[106]  P. A. Crawford,et al.  Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease , 2015, Nature Medicine.

[107]  K. Takimoto,et al.  SIRT1 Suppresses the Senescence-Associated Secretory Phenotype through Epigenetic Gene Regulation , 2015, PloS one.

[108]  B. Fei,et al.  Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis , 2014, Journal of the American Heart Association.

[109]  T. Münzel,et al.  The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity , 2014, PloS one.

[110]  C. Burant,et al.  Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes , 2014, Diabetes.

[111]  J. Halcox,et al.  Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls , 2014, Diabetes, obesity & metabolism.

[112]  J. Campisi,et al.  Senescence and apoptosis: dueling or complementary cell fates? , 2014, EMBO reports.

[113]  Steve Horvath,et al.  Obesity accelerates epigenetic aging of human liver , 2014, Proceedings of the National Academy of Sciences.

[114]  T. Unterman,et al.  Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings. , 2014, Translational research : the journal of laboratory and clinical medicine.

[115]  F. Tacke,et al.  GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6–Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering , 2014, Diabetes.

[116]  J. Yatabe,et al.  Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy. , 2014, Journal of diabetes and its complications.

[117]  F. Paneni,et al.  Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes. , 2014, Cardiovascular diagnosis and therapy.

[118]  L. O’Neill,et al.  Metabolic Reprograming in Macrophage Polarization , 2014, Front. Immunol..

[119]  E. Mercken,et al.  SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass , 2014, Aging cell.

[120]  R. Califf,et al.  Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes , 2014, The Lancet.

[121]  M. Donath.  Targeting inflammation in the treatment of type 2 diabetes: time to start , 2014, Nature Reviews Drug Discovery.

[122]  C. Ling,et al.  Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes , 2014, Diabetes.

[123]  L. Lynch,et al.  Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus , 2014, Diabetologia.

[124]  M. Levine,et al.  Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. , 2014, Cell metabolism.

[125]  D. Giugliano,et al.  Mediterranean diet and type 2 diabetes , 2014, Diabetes/metabolism research and reviews.

[126]  D. Sinclair,et al.  Small molecule SIRT1 activators for the treatment of aging and age-related diseases. , 2014, Trends in pharmacological sciences.

[127]  E. Ballestar,et al.  Geriatric muscle stem cells switch reversible quiescence into senescence , 2014, Nature.

[128]  C. Jenkinson,et al.  The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus , 2014, Acta Diabetologica.

[129]  M. Vinciguerra,et al.  SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation , 2014, Aging.

[130]  M. Monsalve,et al.  SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1α complex. , 2013, Antioxidants & redox signaling.

[131]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[132]  C. Gluud,et al.  Antioxidant supplements to prevent mortality. , 2013, JAMA.

[133]  Soyoung Lee,et al.  Synthetic lethal metabolic targeting of cellular senescence in cancer therapy , 2013, Nature.

[134]  E. Mercken,et al.  Metformin improves healthspan and lifespan in mice , 2013, Nature Communications.

[135]  D. Giugliano,et al.  Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes , 2013, Diabetes Care.

[136]  Masahira Hattori,et al.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome , 2013, Nature.

[137]  Kelly J. Morris,et al.  A complex secretory program orchestrated by the inflammasome controls paracrine senescence , 2013, Nature Cell Biology.

[138]  A. Novials,et al.  Glucose regulation of a cell cycle gene module is selectively lost in mouse pancreatic islets during ageing , 2013, Diabetologia.

[139]  A. Tall,et al.  Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. , 2013, Cell metabolism.

[140]  D. Cai,et al.  Hypothalamic Programming of Systemic Aging Involving IKKβ/NF-κB and GnRH , 2013, Nature.

[141]  C. Stehouwer,et al.  Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. , 2013, The Netherlands journal of medicine.

[142]  Dolores Corella,et al.  Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013, The New England journal of medicine.

[143]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[144]  A. Procopio,et al.  Toll like receptor signaling in “inflammaging”: microRNA as new players , 2013, Immunity & Ageing.

[145]  M. A. Pozo,et al.  Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging , 2013, Aging cell.

[146]  Gang Liu,et al.  Histone Modifications in Senescence-Associated Resistance to Apoptosis by Oxidative Stress☆☆☆ , 2013, Redox biology.

[147]  T. Roeder,et al.  Vitamin E supplementation and lifespan in model organisms , 2013, Ageing Research Reviews.

[148]  G. Di Dalmazi,et al.  Glucocorticoids and Type 2 Diabetes: From Physiology to Pathology , 2012, Journal of nutrition and metabolism.

[149]  Yan Zhang,et al.  A systematic review and meta-analysis , 2012 .

[150]  M. Fraga,et al.  Genome-Wide Analysis of DNA Methylation Differences in Muscle and Fat from Monozygotic Twins Discordant for Type 2 Diabetes , 2012, PloS one.

[151]  C. Benoist,et al.  The immune system's involvement in obesity-driven type 2 diabetes. , 2012, Seminars in immunology.

[152]  N. Miyasaka,et al.  p16INK4a Exerts an Anti-Inflammatory Effect through Accelerated IRAK1 Degradation in Macrophages , 2012, The Journal of Immunology.

[153]  A. Ceriello.  The emerging challenge in diabetes: the "metabolic memory". , 2012, Vascular pharmacology.

[154]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[155]  M. Rane,et al.  Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation , 2012, Oxidative medicine and cellular longevity.

[156]  L. Makowski,et al.  The inflammation highway: metabolism accelerates inflammatory traffic in obesity , 2012, Immunological reviews.

[157]  Sean H. Adams,et al.  Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways[S] , 2012, Journal of Lipid Research.

[158]  T. Saikawa,et al.  Interleukin-6 as an Independent Predictor of Future Cardiovascular Events in Patients with Type-2 Diabetes without Structural Heart Disease , 2012 .

[159]  A. Akhmedov,et al.  Gene Silencing of the Mitochondrial Adaptor p66Shc Suppresses Vascular Hyperglycemic Memory in Diabetes , 2012, Circulation research.

[160]  A. El-Osta.  Redox mediating epigenetic changes confer metabolic memories. , 2012, Circulation research.

[161]  Charles R. Evans,et al.  The Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose Metabolism , 2012, Cell metabolism.

[162]  Patrice D Cani,et al.  Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity , 2012, Gut microbes.

[163]  C. Glass,et al.  Inflammation and lipid signaling in the etiology of insulin resistance. , 2012, Cell metabolism.

[164]  A. Salminen,et al.  Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP). , 2012, Cellular signalling.

[165]  R. Isseroff,et al.  Toll-like receptors and diabetes: a therapeutic perspective. , 2012, Clinical science.

[166]  C. O'Donnell,et al.  Free Fatty Acids Block Glucose-Induced β-Cell Proliferation in Mice by Inducing Cell Cycle Inhibitors p16 and p18 , 2012, Diabetes.

[167]  V. Vaccarino,et al.  Global DNA Methylation Is Associated With Insulin Resistance , 2012, Diabetes.

[168]  M. Dietrich,et al.  Obesity is associated with hypothalamic injury in rodents and humans. , 2012, The Journal of clinical investigation.

[169]  M. Velarde,et al.  Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin , 2012, Aging.

[170]  Z. Darżynkiewicz,et al.  Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling , 2011, Aging.

[171]  J. Campisi,et al.  Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype* , 2011, The Journal of Biological Chemistry.

[172]  R. Simó,et al.  Phagocytic Activity Is Impaired in Type 2 Diabetes Mellitus and Increases after Metabolic Improvement , 2011, PloS one.

[173]  Y. Benno,et al.  Longevity in Mice Is Promoted by Probiotic-Induced Suppression of Colonic Senescence Dependent on Upregulation of Gut Bacterial Polyamine Production , 2011, PloS one.

[174]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[175]  Carey N Lumeng,et al.  Inflammatory links between obesity and metabolic disease. , 2011, The Journal of clinical investigation.

[176]  Seth L Masters,et al.  The Inflammasome in Atherosclerosis and Type 2 Diabetes , 2011, Science Translational Medicine.

[177]  Wei Sun,et al.  The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. , 2011, Cell metabolism.

[178]  J. Cuzick,et al.  The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women , 2011, International Journal of Obesity.

[179]  J. Montani,et al.  Hyperactive S6K1 Mediates Oxidative Stress and Endothelial Dysfunction in Aging: Inhibition by Resveratrol , 2011, PloS one.

[180]  J. Campisi,et al.  p38MAPK is a novel DNA damage response‐independent regulator of the senescence‐associated secretory phenotype , 2011, The EMBO journal.

[181]  R. Petrella,et al.  Effects of Exercise on Cardiovascular Risk Factors in Type 2 Diabetes , 2011, Diabetes Care.

[182]  R. Kowluru,et al.  Epigenetic Changes in Mitochondrial Superoxide Dismutase in the Retina and the Development of Diabetic Retinopathy , 2011, Diabetes.

[183]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[184]  A. Ceriello,et al.  Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells , 2011, Diabetologia.

[185]  E. Ropelle,et al.  Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion. , 2011, Endocrinology.

[186]  L. Pirola,et al.  Epigenetic phenomena linked to diabetic complications , 2010, Nature Reviews Endocrinology.

[187]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[188]  M. Jensen,et al.  Fat tissue, aging, and cellular senescence , 2010, Aging cell.

[189]  M. Marquès,et al.  Adipose Tissue Endothelial Cells From Obese Human Subjects: Differences Among Depots in Angiogenic, Metabolic, and Inflammatory Gene Expression and Cellular Senescence , 2010, Diabetes.

[190]  G. Maulucci,et al.  Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance , 2010, Proceedings of the National Academy of Sciences.

[191]  R. D. de Boer,et al.  Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species–Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[192]  J. Olefsky,et al.  SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. , 2010, American journal of physiology. Endocrinology and metabolism.

[193]  F. Hu,et al.  Saturated fat, carbohydrate, and cardiovascular disease. , 2010, The American journal of clinical nutrition.

[194]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[195]  M. Blagosklonny.  Calorie restriction: Decelerating mTOR-driven aging from cells to organisms (including humans) , 2010, Cell cycle.

[196]  N. Chondrogianni,et al.  Nuclear Erythroid Factor 2-mediated Proteasome Activation Delays Senescence in Human Fibroblasts* , 2010, The Journal of Biological Chemistry.

[197]  K. Siminovitch,et al.  Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells , 2010, Diabetologia.

[198]  R. Testa,et al.  Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes , 2009, Diabetes Care.

[199]  Masayuki Orimo,et al.  A crucial role for adipose tissue p53 in the regulation of insulin resistance , 2009, Nature Medicine.

[200]  F. D. D. Fagagna,et al.  SASPense and DDRama in cancer and ageing , 2009, Nature Cell Biology.

[201]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[202]  S. Mazmanian,et al.  The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.

[203]  G. Hotamisligil,et al.  Nutrient sensing and inflammation in metabolic diseases , 2008, Nature Reviews Immunology.

[204]  M. Karin,et al.  Hypothalamic IKKβ/NF-κB and ER Stress Link Overnutrition to Energy Imbalance and Obesity , 2008, Cell.

[205]  Christoph Handschin,et al.  The role of exercise and PGC1α in inflammation and chronic disease , 2008, Nature.

[206]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[207]  D. Sinclair,et al.  Xenohormesis: Sensing the Chemical Cues of Other Species , 2008, Cell.

[208]  J. Tschopp,et al.  Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.

[209]  Vilmundur Gudnason,et al.  Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review , 2008, PLoS medicine.

[210]  Anja Voigt,et al.  Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. , 2007, Cell metabolism.

[211]  C. Knauf,et al.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.

[212]  H. Ellingsgaard,et al.  Increased Number of Islet-Associated Macrophages in Type 2 Diabetes , 2007, Diabetes.

[213]  J. Holloszy,et al.  Caloric restriction in humans , 2007, Experimental Gerontology.

[214]  Jianghua Chen,et al.  Rapamycin Prevents Early Steps of the Development of Diabetic Nephropathy in Rats , 2007, American Journal of Nephrology.

[215]  P. Calder,et al.  Glucose metabolism in lymphoid and inflammatory cells and tissues , 2007, Current opinion in clinical nutrition and metabolic care.

[216]  AL Gruver,et al.  Immunosenescence of ageing , 2007, The Journal of pathology.

[217]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[218]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[219]  K. Ligon,et al.  p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.

[220]  Antonio Ceriello,et al.  The effects of diet on inflammation: emphasis on the metabolic syndrome. , 2006, Journal of the American College of Cardiology.

[221]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[222]  D. Drucker,et al.  Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor , 2006, Diabetes.

[223]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[224]  R. Holle,et al.  Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). , 2005, Diabetes.

[225]  L. Velloso,et al.  Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. , 2005, Endocrinology.

[226]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[227]  T. Horvath.  The hardship of obesity: a soft-wired hypothalamus , 2005, Nature Neuroscience.

[228]  Mark P Mattson,et al.  Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. , 2005, The Journal of nutritional biochemistry.

[229]  Edward J Calabrese,et al.  Hormesis: a revolution in toxicology, risk assessment and medicine , 2004, EMBO reports.

[230]  G. Paolisso,et al.  Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. , 2003, The American journal of clinical nutrition.

[231]  W. Zwerschke,et al.  Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. , 2003, The Biochemical journal.

[232]  Elie. Metchnikoff.  The Prolongation of Life: Optimistic Studies , 2003 .

[233]  Matthias Blüher,et al.  Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue , 2003, Science.

[234]  R. Marfella,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.

[235]  M. Goligorsky,et al.  Glycated Collagen I Induces Premature Senescence-Like Phenotypic Changes in Endothelial Cells , 2002, Circulation research.

[236]  D. Stephens,et al.  Endotoxin of Neisseria meningitidis Composed Only of Intact Lipid A: Inactivation of the Meningococcal 3-Deoxy-d-Manno-Octulosonic Acid Transferase , 2002, Journal of bacteriology.

[237]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[238]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[239]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[240]  M. Rigoulet,et al.  Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* , 2000, The Journal of Biological Chemistry.

[241]  S. Geerlings,et al.  Immune dysfunction in patients with diabetes mellitus (DM). , 1999, FEMS immunology and medical microbiology.

[242]  H. Cohen,et al.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.

[243]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[244]  J. Pickup,et al.  NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X , 1997, Diabetologia.

[245]  K. Prasad,et al.  Time course study of oxidative stress in aorta and heart of diabetic rat. , 1996, Clinical science.

[246]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[247]  Y. Kan,et al.  Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[248]  K. Federlin,et al.  Impairment of Polymorphonuclear Leukocyte Function and Metabolic Control of Diabetes , 1992, Diabetes Care.

[249]  C. Kahn,et al.  The insulin receptor and the molecular mechanism of insulin action. , 1988, The Journal of clinical investigation.

[250]  P. Mclean,et al.  Renal Hypertrophy in Experimental Diabetes: Changes in Pentose Phosphate Pathway Activity , 1985, Diabetes.

[251]  Qinfei Ke,et al.  Chitosan Wound Dressings Incorporating Exosomes Derived from MicroRNA‐126‐Overexpressing Synovium Mesenchymal Stem Cells Provide Sustained Release of Exosomes and Heal Full‐Thickness Skin Defects in a Diabetic Rat Model , 2016, Stem cells translational medicine.

[252]  Hang Shi,et al.  Changes in adipose tissue macrophages and T cells during aging. , 2014, Critical reviews in immunology.

[253]  Jens Roat Kultima,et al.  Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2015, Nature.

[254]  K. Inoki,et al.  Evaluation of the nutrient-sensing mTOR pathway. , 2012, Methods in molecular biology.

[255]  Stephen A. Martin,et al.  Exercise, inflammation and aging. , 2012, Aging and disease.

[256]  A. Marcos,et al.  Physical activity, exercise and low-grade systemic inflammation , 2010, Proceedings of the Nutrition Society.

[257]  Joseph Rafter,et al.  Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? , 2005, The American journal of clinical nutrition.

[258]  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Somatostatin Receptor SST4 in Human Placenta and Absence of Octreotide Effect on Human Placental Growth Hormone Concentration during , 1997 .

[259]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.